From:  The future of cervical cancer prevention: advances in research and technology

 Overview of the emerging techniques in the prevention of cervical cancer

TechnologyDescriptionApplicationReferences
Thermal ablationUtilizes heat beams to eradicate precancerous cervical lesions.Significant potential for cervical cancer prevention[26]
Liquid-based cytology and automationThis enhances case adequacy and lab productivity, facilitates HPV testing, and is compatible with automated analysis.Enhanced screening efficiency[2729]
Point-of-care HPV molecular testCrucial role in allowing the clinical research team to offer post-test counseling to women who tested positive for HPV.Self-sampling and high-resolution microendoscopy technologies[31, 33]
Molecular testing advancementsGenomic techniques analyze oncogene and tumor suppressor gene profiles at the DNA level, focusing on clinically relevant biomarkers associated with HPV infections.Integration of high-risk HPV DNA detection into prevention efforts, potential for improved risk assessment and triage[36, 37]
Artificial intelligence (AI)AI enhances accuracy and efficiency in interpretation, aids non-invasive differentiation of cervical cancer, and supports triaging of HPV-positive individuals.Real-time and reliable diagnosis, automated recognition of cervical precancer and cancer[3842]
Precision medicineTailoring prevention and treatment strategies based on the genetic, environmental, and lifestyle characteristics of each patient.Genomic techniques for genotype-phenotype associations, digital health interventions for personalized care and support[4749]
CRISPR/Cas9 applicationUtilized for molecular diagnosis, identifying cancer susceptibility genes, treating cervical cancer tumors in mice, targeting HPV and PD-1 for potential human trials.Potential as a versatile tool for research and therapeutic purposes in cervical cancer[6668]
RNA interference (RNAi)Suppression of target genes, reduction in E6 and E7 mRNA levels, apoptosis in cancer cell lines.Promising as a genetic engineering technique for treating cervical cancer[69]
BiomarkersHPV DNA testing, miRNAs, proteins, HPV E6/E7 oncogene transcripts, p16INKa/ki-67, M-CSF, VEGF, DNA methylation, PD-L1 status, mismatch repair status, tumor mutational burden status.Potential in enhancing early detection and prognosis, further research needed for clinical applicability[7073]

PD-1: programmed death 1; PD-L1: programmed death ligand 1; M-CSF: macrophage colony-stimulating factor; VEGF: vascular endothelial growth factor